Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Medicilon

Medicilon is listed as a large business research supplier in the Scientist.com network, with 8 sites in 4 countries and 5 service areas.

View Medicilon on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 8
Countries 4

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Large business

Antibodies

  • Antibody based Assay Development Create specific and sensitive assays for the immunodetection of disease-specific target antigens.
  • Antibody Detection Quantitate, localize and visualize proteins and other antigens.
  • Antibody Products Purchase antibody, antibody pair kit or ELISA kit.
  • Polyclonal Antibody Production Generate polyclonal antibodies in vivo using evolutionary distant animal species.

Biomarkers

  • Anatomic Pathology Do macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues.
  • Biomarker Analytical Validation Assess and optimize the characteristics of a candidate biomarker to ensure reproducibility and consistency.
  • Biomarker Clinical Validation Evaluate the predictive ability of a candidate biomarker for a disorder.
  • Biomarker Discovery Identify a biomarker associated with disease progression of disease, effectiveness of therapy or diagnosis of disease or condition.
  • Histopathology Evaluate slide preparation of cells or tissues for abnormal features.
  • Immunoassays Create antibody-based assays for the identification and quantification of specific antigens.
Show all 9 in Biomarkers 3 more
  • Lipid Kinase Assays Use biochemical, cell-based or in vivo assays to measure lipid kinase activity.
  • Pharmacodynamic Biomarkers Discovery Identify candidate biomarkers indicative of the therapeutic outcome of a drug-target interaction.
  • Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.

Cell Culture and Characterization

  • Cell Line Characterization Track source history and characterize cell lines to establish identity, purity and stability.
  • Cell Line Construction Create new recombinant cell lines to exact specifications.
  • Cell Transfection Produce, package and optimize transfection of your siRNA or DNA construct.
  • Histology Examine by microscopy the anatomy of cells and tissues of clinical patients and animal models.
Show all 186 services 172 more

Chemical and Compound Analysis

  • GLP Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of large biomolecules.
  • GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • Non GLP Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of large biomolecules.
  • Non GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • Protein Binding HPLC Uses high pressure liquid chromatography to separate protein-drug complexes.
  • Protein Crystallization Create high quality protein-ligand crystals for x-ray diffraction studies.
Show all 9 in Chemical and Compound Analysis 3 more
  • Protein Structure Determine the three dimensional structure of a protein by NMR or x-ray crystallography.
  • Sample Bioanalysis Determination of concentration of an analyte in biological sample.
  • Structural Chemistry Examine the relationship between protein structure and function.

Chemistry, Manufacturing and Controls (CMC)

  • API and Drug Product Stability Testing API and Drug Product Stability Testing.
  • Chemistry, Manufacturing and Controls (CMC) Request Chemistry, Manufacturing and Controls services
  • Crystallization studies Crystallization studies
  • Polymorph Screening Screen for unwanted API forms resulting from the drug formulation process.

Clinical Trials

  • Bioequivalence Studies Assess the expected biological equivalence of two proprietary preparations of a drug.
  • Pharmacokinetic Studies Design a study that observes the time course of drug absorption, distribution, metabolism, and excretion, as means to test the safety and effective therapeutic management of drugs in an individual patient.

Developmental and Reproductive Toxicology (DART)

  • Reproductive Toxicology Study adverse sexual function and fertility and examine teratogenicity of compounds.

Discovery Chemistry

  • Compound Purchase Buy compounds, building blocks or compound libraries.
  • Compound Synthesis Synthesize small molecule candidates for use in hit followup, lead optimization and medicinal chemistry.
  • Custom Synthesis Find or synthesize mg to kg amounts of target-specific and target agnostic compounds for HTS and biological screening.
  • Hit to Lead (H2L) Evaluate, perform limited optimization and identify small molecule hits from high throughput screens.
  • Lead Optimization Perform chemical structural changes to improve preclinical drug candidate.
  • QSAR Analysis Develop quantitative structure–activity relationship models for drug design.
Show all 7 in Discovery Chemistry 1 more
  • Virtual Screening Use software algorithms to virtually screen millions of potential compounds and peptides for binding.

Disease Models

  • Arthritis Models Measure therapeutic endpoints in animal models of arthritis.
  • Behavioral Testing Models Investigate sensory-motor and emotional functions, social behavior and day-night activity.
  • Blood Models Test for therapeutic efficacy of drug candidates in blood disorder models.
  • Drug-Induced Liver Injury (DILI) Toxicity Assays Use biochemical, cell-based or in vivo assays to measure toxicity from drug-induced liver injury.
  • In Vivo Technologies Models Carry out EEGs, cognition assessment, microdialysis, electrophysiology, MRI, ultrasound and tomographic analysis.
  • Inflammation Models Measure therapeutic endpoints in animal models for inflammation.
Show all 15 in Disease Models 9 more
  • Inflammatory Bowel Disease Models Measure IBD symptom severity, cytokine levels and body weight, and evaluate IHC and Ariol images.
  • Inflammatory Pain Models Measure therapeutic endpoints in animal models of inflammatory pain.
  • LPS Acute Response Models Measure therapeutic endpoints in acute models of inflammation.
  • Obese Primates Use a single animal species to create one or more disease models for diet-induced obesity and type II diabetes.
  • Pain Endpoints Models Measure therapeutic endpoints in animal models of pain.
  • Pain Models Test therapeutic efficacy of drug candidate in pain model.
  • Parkinson's Disease Models Measure therapeutic endpoints in animal models of Parkinson's disease.
  • Receptor Binding Models Measure the binding and distribution of drugs and biologics in animal tissues.
  • Wound Healing Models Measure therapeutic endpoints in animal models of wound healing.

DNA & RNA

  • RNA Services Whether you’re isolating total RNA for whole genome expression analysis by microarray or setting up high content screening by s...

Drug Development

  • Assay Development Consulting Request consultant services measuring the activity of a drug or biochemical in an organism or organic sample.
  • Chemistry, Manufacturing and Controls (CMC) Consulting Consultant services related to the development of pharmaceutical and biopharmaceutical drug products that are consistently effective, safe and high quality for consumers.

General in vivo Toxicology

  • Dose Range Finding Study - Other Species Conduct a study to determine the dose range of your compound in other species.
  • Dose Range Finding Study - Rat Conduct a study to determine the dose range of your compound in rats.
  • General Toxicology Use in vivo models to assess acute and sub-acute toxicity as well as chronic and sub-chronic toxicity.
  • IV Toxicology Test the toxicological effect of IV delivery of drug candidate.
  • Mammalian Toxicology Use toxicity testing models to carry out required FDA or REACH safety testing.
  • Oral Toxicology Use toxicity studies in animals to evaluate the oral toxicity of a drug candidate.
Show all 12 in General in vivo Toxicology 6 more
  • Repeat Dose Toxicity Study - Mouse Conduct a repeat dose study in mice to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Toxicity Study - Other Species Conduct a repeat dose study in other species to determine the toxicity and toxicokinetic behavior of your compound.
  • Single Dose Acute Toxicity Study - Dog / Canine Conduct a single dose study in Dogs and Canines to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Toxicity Study - Monkey / Non-human Primate Conduct a single dose study in Monkeys and Non-human Primates to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Toxicity Study - Mouse Conduct a single dose study in Mice and Murines to determine the toxicokinetic behavior of your compound.
  • Single Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by a single administration in a 7 day period.

Human Biological Samples

  • 3D InSight™ Liver Microtissues Perform in vitro assessment of islet function for efficacy and toxicity testing.

In Vitro ADME

  • Blood Brain Barrier Measure movement of drugs from circulating blood to brain extracellular fluid.
  • Caco-2 Cell Permeability Measure passive diffusion of drugs across Caco2 cell monolayers.
  • CYP Induction Detect increases in the expression of various isoforms of cytochrome P450 (CYP450).
  • Drug Drug Interactions Determine whether a substance affects the activity of a drug when both are administered together.
  • HT ADME (High-Throughput Absorption, Distribution, Metabolism and Excretion) Analyze the process and effects of a chemical that is ingested by an organism using an advanced technological screening process. Use for drug...
  • Metabolic Stability Measure metabolic vulnerability to drug metabolizing enzymes using cell-free, cell-based and in vivo assays.
Show all 14 in In Vitro ADME 8 more
  • Metabolic Stability in Hepatocytes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver cells.
  • Metabolic Stability in Microsomes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver microsomes.
  • Metabolite Structural Elucidation Use analytical tools to characterize metabolite structure.
  • Phase I Metabolism Use enzymes such as cytochrome P450 oxidases to introduce reactive or polar groups into xenobiotics.
  • Phase II Metabolism Use transferase enzymes such as glutathione S-transferases to conjugate phase I xenobiotics to polar compounds.
  • Plasma Stability Assay Determine degradation rate of drug candidates in plasma.
  • Reactive Metabolite Ensure that your drug candidate is not generating toxic reactive metabolites in vivo.
  • Skin Permeability Use human skin models to determine transdermal delivery and percutaneous absorption of pre-clinical drugs.

In Vitro Assays

  • Apoptosis Assays Detect apoptotic events that lead to programmed cell death.
  • Assay Development Construct or create new assays or modify existing ones.
  • Biosensor Assays Evaluate biological activity of new compounds, detect toxic metabolites or monitor biomarkers.
  • Cell Proliferation Measure cell number, cell viability and cell division.
  • HTS Assay Development Develop assays to use in high throughput screening.
  • In Vitro Assay Development Develop innovative assay and screening methods outside a living organism to enable a wide range of pre-clinical activities.
Show all 9 in In Vitro Assays 3 more
  • Inflammation Assays Identify and validate pro- and anti-inflammatory molecules, recruitment inhibitors and chemotaxis modulators.
  • Phenotype Assays Measure effects of drug candidate on the morphology or function of cells and whole animals.
  • Serine Protease Assay Detect apoptosis by measuring protease activity.

In Vitro Pharmacology

  • G-Protein Coupled Receptor (GPCR) Assays Detect ligand binding, receptor dimerization and downstream signal transduction events.
  • High Throughput Screening Conduct millions of chemical, genetic or pharmacological tests in a short period of time.
  • Immuno-oncology Assays Use biochemical, cell based or in vivo assays to measure the activity of immuno-therapy targets.
  • In Vitro Enzyme Activity Assay Development Develop new in vitro enzyme activity assays or modify existing ones.
  • In Vitro Hemolysis Assay Evaluate the toxicity of a drug, metabolite or excipient by hemolytic release of hemoglobin in the plasma.
  • In Vitro Hepatotoxicity Assays Use in vitro assays to measure hepatoxicity-related activities.
Show all 9 in In Vitro Pharmacology 3 more
  • In Vitro Oncology Models Use cell-based and biochemical models of cancer.
  • Protein Targets Protein Targets are of pharmaceutical interest for drug discovery purposes.
  • Target Validation Demonstrate that modification of target activity has potential therapeutic benefits.

In Vitro Toxicology

  • ADCC and CDC Assay Services Measure toxicity of antibodies.
  • Cardiac Channels Measure the arrhythmia producing potential of test compounds.
  • Cardiomyocyte Toxicity Assess cytotoxic effects of pre-clinical compounds on cardiomyocytes.
  • Cardiotoxicity Evaluate the effect of a compound on heart electrophysiology and muscle function.
  • Cardiovascular Toxicology Measure the toxic effects of pre-clinical compounds.
  • Cytotoxicity Test for effects on cell viability and proliferation
Show all 11 in In Vitro Toxicology 5 more
  • Cytotoxicity Testing Determine whether a cosmetic product or ingredient is toxic to in vitro cell cultures.
  • Genotoxicity Evaluate potential of a compound to cause mutations and chromosomal aberations
  • hERG Inhibition Measure the arrhythmia-producing potential of test compounds.
  • Microelectrode Array Cardiotoxicity Assays Use microelectrode array to measure cardiotoxicity-related activities.
  • Toxicology- in vitro Toxicity testing and model development in vitro on developmental and adult neurotoxicity

In Vivo ADME

  • Absorption studies Study the factors determning how efficiently a compound may enter the bloodstream.
  • Mass Balance Study - Dog / Canine Conduct a study to investigate the plasma pharmacokinetics and excretion of your compound as well as total radioactivity in dogs/canines.
  • Mass Balance Study - Monkey / Non-human Primate Conduct a study to investigate the plasma pharmacokinetics and excretion of your compound as well as total radioactivity in monkeys/non-human primates.
  • Mass Balance Study - Rat Conduct a study to investigate the plasma pharmacokinetics and excretion of your compound as well as total radioactivity in rats.
  • Ocular Distribution Study - Dog / Canine Conduct a study to determine the distribution of your compound in ocular tissues of the dog/canine.
  • Ocular Distribution Study - Monkey / Non-human Primate Conduct a study to determine the distribution of your compound in ocular tissues of the monkey/non-human primate.
Show all 10 in In Vivo ADME 4 more
  • Ocular Distribution Study - Other Species Conduct a study to determine the distribution of your compound in ocular tissues of other species.
  • Ocular Distribution Study - Rabbit Conduct a study to determine the distribution of your compound in ocular tissues of the rabbit.
  • Ocular Distribution Study - Rat Conduct a study to determine the distribution of your compound in ocular tissues of the rat.
  • Tissue Distribution Study the tissues in which a compound or its metabolites, accumulate.

In Vivo Pharmacokinetics

  • In Vivo Pharmacokinetics Run pharmacokinetic studies in animals that measure a drug's absorption, distribution, metabolism and excretion (ADME).
  • In Vivo PK Consulting Expert advice on pharmacokinetics and how specific drugs affect the body to determine function, effectiveness, dosage size, etc…
  • Integrated In Vivo Services Package Process an entire In Vivo Project including: Dose Formulation, PK Screening, ADME-Profiling, Toxicology, Safety Pharmacology, DART, IND Filing from our bundle of suppliers.
  • Mouse Efficacy Monotherapy Use mouse models to determine the anti-cancer efficacy of a drug candidate compared to a positive control.
  • Ocular Pharmacokinetic (PK) Screening - Dog / Canine Conduct a pharmacokinetic screening study in dogs/canines that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
  • Ocular Pharmacokinetic (PK) Screening - Monkey / Non-human Primate Conduct a pharmacokinetic screening study in monkeys/non-human primates that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
Show all 20 in In Vivo Pharmacokinetics 14 more
  • Ocular Pharmacokinetic (PK) Screening - Other Species Conduct a pharmacokinetic screening study in other species that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
  • Ocular Pharmacokinetic (PK) Screening - Rabbit Conduct a pharmacokinetic screening study in rabbits that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
  • Ocular Pharmacokinetic (PK) Screening - Rat Conduct a pharmacokinetic screening study in rats that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
  • Pharmacokinetic (PK) Screening Measure the absorption, distribution, metabolism and excretion of a compound.
  • Pharmacokinetic (PK) Screening - Dog / Canine Run pharmacokinetic studies in dogs that measure a drug’s absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Minipig Run pharmacokinetic studies in minipigs that measure a drug’s absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Monkey / Non-human Primate Conduct a pharmacokinetic screening study in monkeys/non-human primates that measures the absorption, distribution, metabolism and excretion of your compound.
  • Pharmacokinetic (PK) Screening - Mouse Run pharmacokinetic studies in mice that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Other Species Run pharmacokinetic studies in large animals that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Rat Run pharmacokinetic studies in rats that measure a drug's absorption, distribution, metabolism and excretion.
  • Rat Efficacy Combination Use rat models to determine the anti-cancer efficacy and potential synergy of a drug candidate with a standard drug treatment.
  • Rat Efficacy Monotherapy Use rat models to determine the anti-cancer efficacy of a drug candidate compared to a positive control.
  • Repetitive Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by repetitive administrations for 7 days.
  • Repetitive Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by repetitive administrations for 7 days.

Medical Communications

  • Pharmacodynamic/ Pharmacokinetic Reports Create Pharmacodynamic/ Pharmacokinetic reports to report to the appropriate regulatory bodies.

Model Development

  • Japanese White Rabbit Use a single animal species to create one or more disease models for metastatic cancer, hematopoiesis and anemia.
  • Knockin Mice Make targeted insertion of a gene of interest into a specific gene locus to create transgenic mice.
  • SCID/BG Mouse Use a single animal species to create one or more disease models for metastatic cancer.
  • Sprague Dawley Rat Use a single animal species to create one or more disease models for cachexia.
  • Transgenic Models Create animal models engineered for use in a specific therapeutic area.

Non-Human Biospecimen

  • Mouse Cells Acquire fresh or frozen cells including but not limited to RBCs, WBCs, PBMCs, endothelial cells, T cells, fibroblasts, hepatocytes, splenocytes, etc.
  • Rabbit Tissues Acquire fresh or frozen tissues including but not limited to those from the central nervous system, endocrine system, gastrointestinal system, integumentary system, reproductive system, lymphatic system, etc.

Oncology Models

  • Animal Hypoxia Models Measure therapeutic endpoints in hypoxic animal models.
  • Immuno-PDX Utilize the patient-derived xenograft for drug response profiling and biomarker discovery of immuno-oncology drug candidates.
  • Random-Bred Guinea Pig Our vendor services provide high-quality guinea pig models worldwide, for a large number of research applications. The Random-...
  • T11 (Breast Cancer) Measure therapeutic endpoints in animal models of breast cancer.
  • Xenograft Models Measure therapeutic endpoints in cancer models using tumor cells transplanted from a donor of a different species.

Other Specialty Toxicology

  • Biosafety Testing In Vitro Test biologics, raw materials, lot release and viral safety
  • Ocular Phototoxicity Study - Other Species Conduct a study to determine the extent to which your compound is capable of producing phototoxic side effects in ocular tissues of other species.
  • Ocular Phototoxicty Study - Rat Conduct a study to determine the extent to which your compound is capable of producing phototoxic side effects in ocular tissues of rats.
  • Tumorigenicity Testing Test tumor-forming properties of cell products.

Protein Sciences

  • ELISA Detect the presence of antigens recognized by antibodies or find antibodies that recognize an antigen.
  • Peptide Discovery Identifying and developing new peptides.
  • Peptide Synthesis Synthesize custom peptides that are long, have unusual modifications or are cyclic.
  • Protein Binding Determine drug-protein binding interactions
  • Protein Expression Produce recombinant proteins in prokaryotic or eukaryotic systems.
  • Protein Purification Isolate native or recombinant proteins from a sample.
Show all 8 in Protein Sciences 2 more
  • Protein Services Protein analysis and tagging are key steps in understanding the effects of compounds and treatments on your target disease outc...
  • X-Ray Crystallography Elucidate structures of biological macromolecules such as proteins and nucleic acids.

REACH Services

  • OECD 471: Bacterial Reverse Mutation Test (Ames) Measure the mutagenic potential of test compounds.
  • OECD 474: Mammalian Erythrocyte Micronucleus Test The mammalian in vivo micronucleus test is used for the detection of damage induced by the test substance to the chromosomes or the mitotic apparatus of erythroblasts, by analysis of erythrocytes as sampled in bone...

Safety Pharmacology

  • CNS Behavioral Measure safety toxicology effects of CNS and behavioral drugs.
  • Immunotoxicity Measure effects of drugs on immune function, allergic hypersensitization and autoimmune toxicity.
  • Respiratory Toxicology Assess difficulty breathing, altered respiration, blood gas changes and blood pH issues due to adverse reactions.
  • Safety Pharmacology Assess the impact of a therapeutic for human use on vital organ systems before first-in-man drug testing.
  • Safety Pharmacology Latin Square Study - Dog / Canine Conduct a safety pharmacology study with a Latin square design in dogs/canines.
  • Safety Pharmacology Latin Square Study - Other Species Conduct a safety pharmacology study with a Latin square design in other species.
Show all 7 in Safety Pharmacology 1 more
  • Tissue Cross Reactivity Assess the toxic effects of humanized monoclonal antibodies in 33 normal types recommended by the FDA.

Specialty Dosing Routes

  • Dermal Toxicology Assess toxicity in rodent dermal testing models.
  • Inhalation Toxicology Measure toxicity by daily clinical observation, body weight, clinical chemistry, hematology, and terminal necropsy and pathology.
  • Ophthalmologic Toxicology Measure toxicity by microscopy, vitrectomy, tonometry, electroretionography and corneal colorimetry.
  • Repeat Dose Intravenous Infusion Study - Dog / Canine Conduct a repeat dose intravenous infusion study in dogs/canines to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intravenous Infusion Study - Rats Conduct a repeat dose intravenous infusion study in rats to determine the toxicity and toxicokinetic behavior of your compound.

Target Animal and Human Food Safety

  • Toxicokinetic Analysis Determine the drug concentration at which off-target or toxic effects occur.

Testing Services

  • In Vitro Toxicology Testing Non-animal testing employing US and international methodologies for determining irritation and other undesirable potentials.

Other services

  • New Request  

Service areas:

Biology Chemistry DMPK Pharmacology Toxicology

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • China Pudong 4 sites
  • United States Lexington 2 sites
  • Japan Tokyo 1 site
  • Netherlands Wijchen 1 site

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

Shanghai Medicilon provides integrated drug R&D services in the preclinical space, including chemistry, biology, animal studies and integrated discovery programs. Medicilon supports projects in synthetic chemistry, medicinal chemistry, CADD, in vitro assay development and testing, DMPK, ADME, gene expression and protein production, crystallography, structure biology, analytical testing, pharmacology, animal disease models, PK/TK bioanalysis, GLP-toxicology. Medicilon uses its AAALAC accredited facilities to conduct animal studies in rodents, canines, non-human primates and other species.

Website
www.medicilon.com

Source: Scientist.com supplier network, written by the supplier

Get the Medicilon report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with Medicilon on Scientist.com

For prices, more details, or to contact Medicilon, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.